Skip to content

Released Mar 11, 2016, after the close

10-K filed Mar 11, 2016, 71 days after period end · 0001144204-16-087539

Q4 2015 · 10-K
Revenue—
Net Income-$7.75MN/M vs Q4 2014N/M vs Q3 2015
EPS Diluted-$0.45no prior Q4 2014 on fileN/M vs Q3 2015
Operating Incomederived-$8,176,281N/M
Operating Cash Flowderived-$5,455,200N/M
Free Cash Flowderived-$5,465,470N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2015Q4 2014derived from reported figuresQ4 2013derived from reported figuresQ4 2012
Net Income-$7.75M-$6.23M-$6.05M-$3.79M
EPS Diluted-$0.45——-$0.29

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR